Grant Support

Lawrence Eichenfield, MD

DurationContract TitleGrant
Sept. 2008-PresentClinical Evaluation of T.R.U.E TEST(r) Panel 1.1, 2.1, and 3.1 in Children and Adolescents Allerderm.$155,924 
Mar. 2008- Present

An Investigator-Blinded, Randomized, Community, Based, Phase Four Study to Assess Facial Acne Improvement and Tolerability with Use of RETIN-A MICRO(r) (Tretinioin Gel) Microsphere, 0.04% in a Pump Dispenser in a Pediatric Population Johnson and Johnson/OrthoNeutrogena.

$166,068
Jan. 2008-Present

A Phase 2B Multi-Center, Double-Blind, Randomized, Dose-Ranging Clinical Trial to Evaluate IDP-107 in the Treatment of Moderate to Severe Acne Vulfatis with Nodular Involvement.

$30,125
Jan. 2008-PresentA Randomized, Double-Blind, Placebo-Controlled, Dose Response Study for the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Epidermolysis Bullosa. $13,048
June 2008-Dec. 2008A Randomized, Double-Blind, Comparative, Crossover study to Evaluate the Tolerance and Efficacy of SS Baby Sunblock Lotion SPF 60, 1321-126 to a Commercial Benchmark Product in Babies and Children Neutrogena.$86,499
June 2007-Present A Multi-Center, Open-Label Study to Evaluate the Effect of Altana Inc’s CutivateLotion 0.05% on the Hypothalamic Pituitary Adrenal Axis in the Treatment of Atopic Dermatitis in a Pediatric Population$44,283
Oct. 2007- PresentMethod Evaluation for Buccal Swab Collection - a substudy of CASM981C US09 Novartis (Amendment#2 Fillagrin).$18,175
Oct. 2007-PresentA Multi-Center, Randomized, Double-Blind, Parallel Group Study to Demonstrate the Efficacy and Safety of Adapalene Lotion, 0.1% Compared with Vehicle Lotion in Subjects with Acne Vulgaris.$123,543
Aug. 2007-PresentEvaluation of the Cutaneous Innate Immune and Clinical Response to Oral and Topical Vitamin D UCSD/CSSD/RCHSD Intramural Grant.$50,000
Jan. 2006-PresentAn Open-label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects with Plaque Psoriasis.$251,799.98
Dec. 2006-PresentA Placebo-Controlled, Double-blind, Randomized Parallel Group Exploratory Study of the Safety and Efficacy of JNJ-26113100 in the Treatment of Adult Atopic Dermatitis That is Moderate in Severity.$85,477 
Dec. 2006- PresentPK and PD of Calcitriol Following Twice Daily Application of Calcitriol 3µg/g Ointment under Conditions of Maximal Use on Adolescents with Plaque Psoriasis RD.06.SPR.18102/Galderma.$101,321
Jan. 2006- PresentA Prospective Pediatric Longitudinal Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis APPLES/Astellas.$19,000
Dec. 2005-PresentA 5-year Prospective Study in Infants with Atopic Dermatitis to Determine Risk Factors, with a Focus on Pets and Pests, on the Development of Asthma and Allergic Diseases CASM981C US26/Novartis.$11,907
Apr. 2002- PresentAn Investigation of the Safety and Efficacy of Elidel 1% Cream in Atopic Disease Modification, Assessed in a 3 Year Randomized, Double-Blind, Vehicle-Controlled Phase to Evaluate effects on Atopic Dermatitis in Infants, and a 2-3 Year Open-Label Phase to Evaluate the Effect of Early Intervention Versus Delayed Intervention with Elidel on the Incidence of Asthma in Children Novartis.$508,625


Sheila Fallon Friedlander, MD

DurationContract TitleGrant
2007-PresentA Prospective Two-Year Longitudinal Study To Assess For Miconazole Resistance In Candida Spp. With Repeated Treatment Courses Of 0.25% Miconazole Nitrate Ointment In Neonates Infants Up To 1 Year Aug. Of Age With Recurrent Moderate To Severe Diaper Dermatitis Complicated By Cutaneous Candidiasis.$65,894
Feb. 2006-PresentA Prospective StudyComparing the Incidence of Infantile Hemangiomas Following Normal Pregnancies versus Pregnancies Complicated by Placental Abnormalities Skaggs Scholar Grant.$444,690


Wynnis L. Tom, MD

DurationContract TitleGrant
Mar. 2008-Feb. 2009Genetic Variation in a T-cell Signaling Pathway and its Influence on Pediatric Psoriasis UCSD/Peds.$38,150
July 2008-Dec. 2009Oral Azathioprine and pediatric atopic dermatitis: evaluation of the cutaneous antimicrobial barrier and immune response Pilot Project Award, Society for Pediatric Dermatology.$7,500